Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study

DSpace Repository

Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study

Author: Larkin, James; Del Vecchio, Michele; Ascierto, Paolo A.; Krajsova, Ivana; Schachter, Jacob; Neyns, Bart; Espinosa, Enrique; Garbe, Claus; Sileni, Vanna Chiarion; Gogas, Helen; Miller, Wilson H., Jr.; Mandala, Mario; Hospers, Geke A. P.; Arance, Ana; Queirolo, Paola; Hauschild, Axel; Brown, Michael P.; Mitchell, Lada; Veronese, Luisa; Blank, Christian U.
Tübinger Autor(en):
Garbe, Claus
Published in: Lancet Oncology (2014), Bd. 15, H. 4, S. 436-444
Verlagsangabe: Elsevier Science Inc
Language: English
Full text: http://dx.doi.org/10.1016/S1470-2045(14)70051-8
ISSN: 1470-2045
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)